Cover Image
QR Code

Formulating Drugs for Continuous Processing: Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented.

Published in:Pharmaceutical Technology Europe Vol. 35; no. 4; pp. 16 - 19
Main Author: Thomas, Felicity
Format: pictorial Journal Article
Published: MJH Life Sciences Apr2023
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163305339&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 163305339
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17537967
        5NG
      jtl: Pharmaceutical Technology Europe
      issn: 17537967
      maglogo: N
    pubinfo:
      dt: Apr2023
      vid: 35
      iid: 4
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        163305339
        163305339
        163305339
        163305339
      ppf: 16
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Formulating Drugs for Continuous Processing: Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented.
      aug:
        au: Thomas, Felicity
      sug:
        subj:
          Chemistry, Pharmaceutical
          Drug Design
          Technology, Pharmaceutical
          Manufacturing Industry
          United States Food and Drug Administration
          Legislation, Drug
          United States
      pubtype: Trade Publication
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N